Holdings of Invesco Biotechnology & Genome ETF
Invesco Exchange-Traded Fund Trust ·30 declared positions · as of Apr 30, 2026
Original filing · Net assets 247.4M $ · Ten largest lines: 47.2 % of the equity sleeve
Sector breakdown
- Health care 35.6 %
- Materials 4.9 %
- Industrials 2.5 %
- Unattributed 57.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 100.0 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 30 | 247.5M $ | 100.00 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | United Therapeutics Corp | 27,212 | 15.5M $ | 6.28 % |
| 2 | Illumina Inc | 104,832 | 13.3M $ | 5.37 % |
| 3 | Biogen Inc | 66,025 | 12.5M $ | 5.05 % |
| 4 | Incyte Corp | 127,499 | 12.1M $ | 4.91 % |
| 5 | Alnylam Pharmaceuticals Inc | 38,706 | 12M $ | 4.84 % |
| 6 | Regeneron Pharmaceuticals, Inc. | 16,684 | 11.8M $ | 4.77 % |
| 7 | Amgen Inc | 33,651 | 11.7M $ | 4.71 % |
| 8 | Gilead Sciences Inc | 87,264 | 11.4M $ | 4.62 % |
| 9 | BioCryst Pharmaceuticals Inc | 923,458 | 8.5M $ | 3.42 % |
| 10 | Catalyst Pharmaceuticals Inc | 290,513 | 8.2M $ | 3.30 % |
| 11 | Arrowhead Pharmaceuticals Inc | 110,374 | 8.1M $ | 3.28 % |
| 12 | Protagonist Therapeutics Inc | 80,415 | 8M $ | 3.22 % |
| 13 | TG Therapeutics Inc | 230,335 | 7.8M $ | 3.15 % |
| 14 | Royalty Pharma PLC | 154,791 | 7.8M $ | 3.13 % |
| 15 | CareDx Inc | 365,065 | 7.6M $ | 3.07 % |
| 16 | Neurocrine Biosciences Inc | 53,660 | 7.1M $ | 2.86 % |
| 17 | Exelixis Inc | 155,682 | 6.9M $ | 2.80 % |
| 18 | Bio-Techne Corp | 122,004 | 6.7M $ | 2.73 % |
| 19 | PTC Therapeutics Inc | 101,877 | 6.6M $ | 2.68 % |
| 20 | Veracyte Inc | 196,903 | 6.5M $ | 2.62 % |
| 21 | ACADIA Pharmaceuticals Inc | 285,787 | 6.4M $ | 2.59 % |
| 22 | Vericel Corp | 183,726 | 6.4M $ | 2.58 % |
| 23 | Halozyme Therapeutics Inc | 99,880 | 6.4M $ | 2.57 % |
| 24 | Repligen Corp | 52,183 | 6.2M $ | 2.50 % |
| 25 | Theravance Biopharma Inc | 368,704 | 6.2M $ | 2.50 % |
| 26 | Ionis Pharmaceuticals Inc | 82,240 | 6.1M $ | 2.49 % |
| 27 | BioMarin Pharmaceutical Inc | 112,225 | 6.1M $ | 2.45 % |
| 28 | Collegium Pharmaceutical Inc | 155,578 | 5.2M $ | 2.12 % |
| 29 | QIAGEN NV | 144,898 | 5M $ | 2.03 % |
| 30 | MannKind Corp | 1,268,504 | 3.6M $ | 1.45 % |